featured
Dupilumab for Moderate-to-Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis Inadequately Controlled by Topical Treatments: A Randomised, Placebo-Controlled, Dose-Ranging Phase 2b Trial
Lancet 2016 Jan 01;[EPub Ahead of Print], D Thaçi, EL Simpson, LA Beck, T Bieber, A Blauvelt, K Papp, W Soong, M Worm, JC Szepietowski, H Sofen, M Kawashima, R Wu, SP Weinstein, NM Graham, G Pirozzi, A Teper, ER Sutherland, V Mastey, N Stahl, GD Yancopoulos, M ArdeleanuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.